Abstract

Since 2008, propranolol has been increasingly used to treat infantile hemangiomas (JW Dermatol Jun 20 2008). Facial hemangioma is part of the constellation of congenital anomalies that make up PHACES syndrome (Posterior fossa malformations, facial Hemangioma, Arterial anomalies, Cardiac anomalies, Eye anomalies, and Sternal/ventral defects). Because cerebrovascular malformations, the main risk factor for stroke in healthy children, are associated …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.